Armata Pharmaceuticals, Inc. (ARMP) Insider Ownership

Historic Insider Ownership Trends

Over the 90-day window ending February 07, 2026, Armata Pharmaceuticals's three dominant insider ownership positions are held by Director Inc. Innoviva, (16.37Mn shares), Chief Executive Officer Deborah Birx (217.38K shares), Chief Business Officer Pierre Kyme (10.49K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Inc. Innoviva, 16,365,969 01 Apr, 2022
Deborah Birx Chief Executive Officer 217,377 14 Jul, 2025
Pierre Kyme Chief Business Officer 10,491 25 Apr, 2025
Richard Rychlik Corporate Controller And Pfo 10,000 18 Mar, 2024

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
10 Jul, 2025 Deborah Birx Common Stock D 13,637 $2.27 217,377 D F
14 Mar, 2025 Pierre Kyme - - 10,491 D
14 Mar, 2025 Pierre Kyme Common Stock D 1,027 $1.95 10,491 D F
14 Mar, 2024 Deborah Birx Common Stock A 60,000 $0.00 260,000 D A
14 Mar, 2024 Richard Rychlik - - 10,000 D
14 Mar, 2024 Richard Rychlik Common Stock A 10,000 $0.00 10,000 D A
21 Dec, 2023 Deborah Birx Common Stock A 200,000 $0.00 200,000 D A
31 Mar, 2022 Inc. Innoviva, Common Stock A 5,385,208 $5.00 16,365,969 I P
09 Feb, 2022 Inc. Innoviva, Common Stock A 3,614,792 $5.00 10,980,761 I P
09 Feb, 2022 Inc. Innoviva, - - 10,980,761 I
29 Oct, 2021 Inc. Innoviva, Common Stock A 1,212,122 $3.30 7,365,969 I P
17 Mar, 2021 Inc. Innoviva, Common Stock A 4,285,935 $3.25 6,153,847 I P
26 Jan, 2021 Inc. Innoviva, Common Stock A 1,867,912 $3.25 1,867,912 I P
27 Mar, 2020 Inc. Innoviva, Common Stock A 7,717,661 $2.87 8,710,800 D P
27 Mar, 2020 Inc. Innoviva, - - 8,710,800 D
08 Dec, 2017 Paul C Grint - - 43 D
08 Dec, 2017 Paul C Grint Common Stock A 599 $0.62 43 D A
29 Dec, 2016 Randal J Kirk Common Stock D 21,923 $0.45 376 I S
29 Dec, 2016 Randal J Kirk - - 376 I
29 Dec, 2016 Randal J Kirk Common Stock D 20,077 $0.45 344 I S